Clinical Research Directory
Browse clinical research sites, groups, and studies.
Characterizing Outcomes and Real-World Experience of Cardiac Physiologic Pacing (The CORE-CPP Study)
Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Summary
The purpose of this study is to use real-world evidence to validate that conduction system pacing (CSP), delivered via a Medtronic 3830 catheter-delivered lead and a Medtronic dual-chamber transvenous pacemaker, is a safe and effective alternative to biventricular pacing (BVP) in patients indicated for cardiac resynchronization therapy (CRT) to deliver cardiac physiologic pacing (CPP), as documented in the clinical literature.
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
6000
Start Date
2017-01-01
Completion Date
2030-12-31
Last Updated
2025-03-26
Healthy Volunteers
No
Conditions
Interventions
Conduction system pacing
Implant with a Medtronic dual-chamber transvenous pacemaker on or after the study data with lead type and placement data indicating conduction system pacing
Bi-ventricular pacing
Implant with a Medtronic bi-ventricular pacemaker (CRT-P) on or after the study date
Locations (1)
Medtronic
Mounds View, Minnesota, United States